Neurocrine Biosciences, Inc. (NBIX) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

NBIX rapporto: 44%

100%

NBIX supera 15 di 34 ultime stime

Data del prossimo reportOct 29, 2024

Stimato per Q3 24:$1.45

Cambiamenti implicati per il Q2 24:+130.16%

Cambiamenti implicati per il Q3 23:+76.83%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 1, 2024	$0.63 / $1.15	$-0.52 / -45.22%
Q1 24	May 1, 2024	$0.42 / $1.04	$-0.62 / -59.62%
Q4 23	Feb 7, 2024	$1.44 / $1.13	$0.31 / 27.43%
Q3 23	Oct 31, 2023	$0.82 / $0.91	$-0.09 / -9.89%
Q2 23	Aug 1, 2023	$0.95 / $0.77	$0.18 / 23.38%
Q1 23	May 3, 2023	$-0.79 / $0.26	$-1.05 / -403.85%
Q4 22	Feb 6, 2023	$0.88 / $1.15	$-0.27 / -23.48%
Q3 22	Nov 1, 2022	$0.69 / $0.84	$-0.15 / -17.86%

Fornitori di Dati: Xignite Logo